Even though the research has led to important progress in understanding the pathophysiology of AD, the exact molecular and cellular mechanisms underlying the disease still remain unknown and the therapeutic strategies targeting Aβ and tau pathways have largely failed or still remain controversial [6–16]. Here, MAPT is linked to Alzheimer disease.